PFA Monitoring Agency Report for the quarter ended 30/06/2026.

JAINEX AAMCOL LIMITED Regd Off.: L-3, MIDC Industrial Area P.O. Chikalthana Aurangabad - 431006 Email: accounts@jainexgroup.com CIN: L74999MH1947PLC005695 August 07, 2026 BSE Limited Listing Operations Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai - 400 001 DSuebar: SSuirbs,m ission of Monitoring Agency Report for the Quarter ended 30th June, 2026 Dear Sir/Ma’am, Pursuant to Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 82(4) of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, please find enclosed the Monitoring Agency Report for the quarter ended 30 June, 2026 issued by CARE Ratings Limited appointed to monitor the utilization of proceeds of the Rights Issue of the Company. This is for your information and records. Thanking you, Yours sincerely, For JAINEX AAMCOL LIMITED Kunal Bafna Whole-time Director and CFO DIN: 00902536 Monitoring Agency Report No. CARE/PRO/GEN/2026-27/1052 The Board of Directors Jainex Aamcol Limited L-3, MIDC Industrial Area., P.O. Chikalthana, Aurangabad- 431 006 Maharashtra August 07, 2026 Dear Sir/Ma’am, Monitoring Agency Report for the quarter ended June 30, 2026 - in relation to the Rights issue of Jainex Aamcol Limited (“the Company”) We write in our capacity of Monitoring Agency for the Rights Issue for the amount aggregating to Rs.8.98 crore of the Company and refer to our duties cast under 82 of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended June 30, 2026, as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated August 20, 2025. Request you to kindly take the same on records. Thanking you, Yours faithfully, Ashish Kashalkar Associate Director Ashish.kashalkarcareedge.in Report of the Monitoring Agency Name of the issuer: Jainex Aamcol Limited For quarter ended: June 30, 2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: No deviation (b) Range of Deviation: Not Applicable Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name and designation of the Authorized Signatory: Ashish Kashalkar Designation of Authorized person/Signing Authority: Associate Director 1) Issuer Details: Name of the issuer : Jainex Aamcol Limited Name of the promoter : Jainex Foods Private Limited, Bharati Bafna, Kunal Bafna and Bhagat Singh Dugar Industry/sector to which it belongs : Consumer Discretionary - Automobile and Auto Components - Auto Components & Equipments 2) Issue Details Issue Period : December 01, 2025 to December 09, 2025 Type of issue (public/rights) : Rights Issue Type of specified securities : Equity Share IPO Grading, if any : Not applicable Issue size (in crore) : Rs.8.98 crore (Refer to Note 1 below) Note 1: The company allotted 7,48,169 equity shares under the rights issue at Rs.120 per share (including a share premium of Rs.110 per share), aggregating to Rs.8.98 crore. Out of this, Rs.7.43 crore was received from investors in the bank allotment account. The balance amount of Rs.1.55 crore, relating to unsecured loans payable to Coventry Metals Rajasthan Private Limited, Jainex Foods Private Limited and Mr. Kunal Bafna, was adjusted against the subscription amount payable by them towards the rights issue, in lines with the offer document dated November 14, 2025 and the board resolution dated November 24, 2025. Accordingly, Rs.1.55 crore was not received in the bank allotment account and has been adjusted against repayment of unsecured loans. 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Source of information / Comments of the certifications considered by Comments of the Particulars Reply Board of Monitoring Agency for Monitoring Agency Directors preparation of report • There has been a delay in the utilization of funds towards one of the objects (To Partially Fund the Expansion Program). The original timeline for utilization was March 31, 2026 as per the offer document. However, the Board, vide Offer document, Board resolution dated November 24, 2025, authorized the CFO of Resolution, Chartered the company to revise the timelines specified in the offer Accountant (CA) document, if required. Accordingly, the CFO, vide letter Whether all utilization is as per the disclosures in the No Certificate*, Bank dated March 25, 2026, revised the timeline for utilization to No Comments Offer Document? statements, Supporting April 30, 2026. documents and • As per the Offer Document, any surplus remaining under the Management certificate issue expenses head was proposed to be utilized for repayment of secured loans. However, since the secured loans had already been fully repaid, the Company utilized the surplus towards the expansion programme, in line with the Board Resolution dated February 13, 2026. Whether shareholder approval has been obtained in Not Offer document and case of material deviations# from expenditures Not Applicable No Comments Applicable Management certificate disclosed in the Offer Document? As per the board resolution dated December 10, 2025, the company has revised the cost of each object, wherein it has reduced the allocation of funds by Rs.1.92 crore for ‘Towards part repayment of secured loans availed to fund the expansion program’ Object and adjusted the same against all other objects. Whether the means of finance for the disclosed Offer document, Board Yes No Comments objects of the issue have changed? Resolution Further, pursuant to Board Resolution dated February 13, 2026, “consent of the Board be and is hereby accorded that in the event any portion of the funds allocated towards Rights Issue Expenses remains unutilised upon completion of all such expenses, the unutilised balance shall be utilised towards the Expansion Programme of the Company.” Is there any major deviation observed [Showing first 8,000 characters — download PDF for full document]